Literature DB >> 12179986

mRNA differential display of gene expression in colonic carcinoma.

Pekka Ojala1, Jari Sundström, Juha M Grönroos, Eveliina Virtanen, Kati Talvinen, Timo J Nevalainen.   

Abstract

We analyzed changes in gene expression in human colonic carcinoma by fluorescent mRNA differential display. RNA isolated from two samples of normal colon and four cases of colonic adenocarcinoma were amplified with a 15 x 32 set of primers resulting in 2880 cDNAs analyzed with an automated sequencer. Electrophoretic patterns implying constitutive gene expression as well as upregulated and downregulated expression in carcinomas were identified. Forty such cDNA fragments were purified by a novel fluorescent polyacrylamide gel electrophoresis (PAGE)-based method and identified by cyclic sequencing. Most genes showing differential expression were upregulated in colonic carcinoma. Upregulated genes included those for various ribosomal and mitochondrial proteins, heat shock proteins, nucleolar RNA-helicase and phosphoserine aminotransferase. Downregulated genes included histone H3.3. In conclusion, genes associated with vital cellular functions such as transcription, protein synthesis and mitochondrial metabolism were upregulated in colonic carcinoma. Fluorescent mRNA differential display can be applied to the identification of novel cancer-related genes for diagnostic, prognostic and therapeutic purposes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12179986     DOI: 10.1002/1522-2683(200206)23:11<1667::AID-ELPS1667>3.0.CO;2-0

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  7 in total

Review 1.  Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications.

Authors:  Wei Wang; Subhasree Nag; Xu Zhang; Ming-Hai Wang; Hui Wang; Jianwei Zhou; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2014-08-28       Impact factor: 12.944

2.  Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation.

Authors:  Jiangbin Ye; Anthony Mancuso; Xuemei Tong; Patrick S Ward; Jing Fan; Joshua D Rabinowitz; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

3.  Identification of differential proteins in colorectal cancer cells treated with caffeic acid phenethyl ester.

Authors:  Yu-Jun He; Wan-Ling Li; Bao-Hua Liu; Hui Dong; Zhi-Rong Mou; Yu-Zhang Wu
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

4.  Toxicogenomic analysis of exposure to TCDD, PCB126 and PCB153: identification of genomic biomarkers of exposure to AhR ligands.

Authors:  Bladimir J Ovando; Corie A Ellison; Chad M Vezina; James R Olson
Journal:  BMC Genomics       Date:  2010-10-19       Impact factor: 3.969

5.  Overexpression of the PSAT1 Gene in Nasopharyngeal Carcinoma Is an Indicator of Poor Prognosis.

Authors:  Kuang-Ming Liao; Tung-Bo Chao; Yu-Feng Tian; Ching-Yih Lin; Sung-Wei Lee; Hua-Ying Chuang; Ti-Chun Chan; Tzu-Ju Chen; Chung-Hsi Hsing; Ming-Jen Sheu; Chien-Feng Li
Journal:  J Cancer       Date:  2016-05-25       Impact factor: 4.207

6.  An integrated pan-cancer analysis of PSAT1: A potential biomarker for survival and immunotherapy.

Authors:  Mingtao Feng; Huanhuan Cui; Wenjing Tu; Liangdong Li; Yang Gao; Lei Chen; Deheng Li; Xin Chen; Fengfeng Xu; Changshuai Zhou; Yiqun Cao
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

7.  Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells.

Authors:  Nadia Vié; Virginie Copois; Caroline Bascoul-Mollevi; Vincent Denis; Nicole Bec; Bruno Robert; Caroline Fraslon; Emmanuel Conseiller; Franck Molina; Christian Larroque; Pierre Martineau; Maguy Del Rio; Céline Gongora
Journal:  Mol Cancer       Date:  2008-01-25       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.